Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc., trading under the ticker UPTD, is a clinical-stage biopharmaceutical company that reached the public markets through a SPAC transaction targeting the immunology and oncology sector. The company filed an 8-K with the SEC on December 29, 2022, signaling a material corporate event during a period of active SPAC deal activity in the life sciences space. The transaction reflects the continued use of blank-check vehicles as a pathway for development-stage biopharma companies seeking public market access. For complete filing history, deal terms, sponsor details, and pipeline data on UPTD and hundreds of other SPAC transactions, create a free account at SpacDesk.